Current Edition


Scientists develop the first blood test for melanoma detection

The new blood test detects the autoantibodies produced in the body in response to the melanoma. Scientists at the Edith Cowan University (ECU), Australia, have …

Continue Reading →

Cancer Research UK tests first of its kind vaccine to treat lung cancer

 A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer (NSCLC), under a …

Continue Reading →

Brexit boom ahead for Dutch clinical trials and human test subjects

The arrival of the European Medicines Agency in Amsterdam next year will be a major boost for the Netherlands’ own drugs testing sector, and moves …

Continue Reading →

Proteomics launches diagnostic test leader ‘PromarkerD’

Proteomics International is engaged with potential partners to bring PromarkerD to market in mainland USA, Mexico, Japan, Australia, China and Europe. MedTech pioneer Proteomics International …

Continue Reading →

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker panel in the blood. …

Continue Reading →